Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.0%

12 terminated/withdrawn out of 100 trials

Success Rate

75.5%

-11.1% vs industry average

Late-Stage Pipeline

12%

12 trials in Phase 3/4

Results Transparency

0%

0 of 37 completed trials have results

Key Signals

16 recruiting9 terminated

Enrollment reporting

Analytics

N/A
54(70.1%)
Phase 4
10(13.0%)
Phase 2
8(10.4%)
Phase 1/2
3(3.9%)
Phase 3
2(2.6%)
77Total
N/A(54)
Phase 4(10)
Phase 2(8)
Phase 1/2(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (100)

Showing 20 of 100 trials
NCT07907692Not ApplicableNot Yet Recruiting

Impact of High Thoracic Paravertebral Block on Diaphragmatic Function: a Prospective Study

Role: lead

NCT07902518Not ApplicableRecruiting

Theta-Burst Transcranial Magnetic Stimulation for Treatment-Resistant Auditory Hallucinations

Role: lead

NCT05615194Not ApplicableTerminated

The Impact of a Single Dexmedetomidine Bolus on Intraoperative Sevoflurane Consumption (DEXHALE)

Role: lead

NCT06684197Not ApplicableRecruiting

The Impact of a Dexmedetomidine Perfusion on Intraoperative Remifentanil Consumption

Role: lead

NCT03596424Not ApplicableTerminated

Dexmedetomidine and Ketamine in VATS Surgery

Role: lead

NCT05749094Recruiting

Optic Nerve Sheath Ultrasound in Giant Cell Arteritis

Role: collaborator

NCT05534945Not ApplicableCompleted

PIB for Post-operative Analgesia After Laparotomy : Determining the Optimum Dose

Role: lead

NCT07228949Completed

Complex Regional Pain Syndrome: Analgesic Outcome

Role: lead

NCT07013734Not Yet Recruiting

Patient Positioning and Its Influence on BIS, NOL, and Cerebral Oxygenation in Anesthetized Patients

Role: lead

NCT07644299Not ApplicableNot Yet Recruiting

Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept Study

Role: lead

NCT05963308Not ApplicableCompleted

Promoting Sustainable Return to Work Among Employees on Sick Leave Due to a Mental Health Condition: Evaluation of the HealthyMinds Online Group Intervention

Role: collaborator

NCT05913674Phase 2Recruiting

Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)

Role: lead

NCT03413800Phase 2Completed

Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant

Role: lead

NCT06972368Not ApplicableRecruiting

Home-Based tDCS for Depression in BPD

Role: lead

NCT04728048Not ApplicableCompleted

Dural Puncture Epidural VS Standard Epidural on Physician Top-ups During Labour Analgesia

Role: lead

NCT05713877Phase 2Recruiting

Melatonin for Treatment of Delirium in Critically Ill Adult Patients

Role: lead

NCT06391814Not ApplicableCompleted

Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)

Role: lead

NCT03441958Phase 1/2Completed

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

Role: lead

NCT06279676Recruiting

Improvement of Women's Health After Allogeneic Stem Cell Transplantation

Role: lead

NCT07477210Active Not Recruiting

Examine the Epidemiology and Outcomes of Transitions From PD-to-HD in Canada

Role: lead